Press Release

ASKA Pharmaceutical Signs a Co-promotion Agreement withMelody International for “Fetal Monitor iCTG” in JapanTOKYO, July 19, 2022 - ASKA Pharmaceutical Co., Ltd. (Head Office: Minato-ku, Tokyo/President, Representative Director: Sohta Yamaguchi), a subsidiary of ASKA PharmaceuticalHoldings Co., Ltd. (Head Office: Minato-ku, Tokyo/ President, Representative Director: TakashiYamaguchi), has concluded a co-promotion agreement in Japan with Melody International Ltd.
(Head Office: Takamatsu City, Kagawa/ President, Yhuko Ogata) for a controlled medical device
Class II, Specially designated maintenance control required medical device “Fetal Monitor iCTG”
manufactured and distributed by Melody International Ltd. as shown in the attachment.
The impact of this matter on the Company's financial results for the fiscal year ending March 31,
2023 will be immaterial.

Media Contacts
ASKA Pharmaceutical Holdings Co., Ltd.
Corporate Planning Department
Tel: +81-3-5484-8366
Email: kouhou@aska-pharma.co.jp

News Release
Melody International and ASKA Pharmaceutical Signs a Co-promotion
Agreement for “Fetal Monitor iCTG” in JapanTOKYO, July 19, 2022 - Melody International Ltd. (Head Office: Takamatsu City, Kagawa/President, Yhuko Ogata, hereinafter referred to as “Melody”) and ASKA Pharmaceutical Co., Ltd.
(Head Office: Minato-ku, Tokyo/ President, Representative Director: Sohta Yamaguchi,
hereinafter referred to as “ASKA”) have concluded a co-promotion agreement in Japan for acontrolled medical device Class II, specially designated maintenance control required medical
device “Fetal Monitor iCTG” manufactured and distributed by Melody.
Based on this co-promotion agreement, Melody and ASKA will jointly provide information on the“Fetal Monitor iCTG” to medical institutions from October in 2022.
In the field of “Femtech” which has been attracting attention in recent years, Melody and ASKA
will contribute to the creation of a safer and more secure environment for pregnant women to givebirth through the promotion of the innovative ICT-based remote medical device “Fetal MonitoriCTG”.
About Fetal Monitor iCTG
It is a mobile delivery monitoring device that enables the health status of mother and child to bemonitored anytime, anywhere. It was developed and commercialized by Melody as a controlled
medical device Class II, specially designated maintenance control required medical device “FetalMonitor iCTG” and was launched in Japan in 2019. It is used in 12 countries overseas, including
in demonstration studies.
About Femtech
Femtech is a coined word that combines “female” and “technology”, and refers to products andservices that use technology to solve women's health issues. The genres range from menstruation,
infertility treatment, childbirth, childcare, child rearing, gynecological disorders, care items forwomen, sexual wellness, and many more. Many women have endured these problems and issues
because of the belief that they are different for each individual and that it is not worth consultingwith someone else. Femtech is a tool that provides solutions by examining what can be done toresolve them so that all people can live healthy and happy lives.

About Melody International Ltd.
Melody, a Kagawa University startup, has been confronting the issue of obstetric care in the local
Setouchi region, which has many remote islands and underpopulated medical areas, as well as
the “shortage of obstetricians” in developing countries around the world as a J-Startup certifiedcompany. As an epoch-making solution to these issues, Melody has developed andcommercialized “fetal monitor iCTG” and a perinatal telemedicine platform, “Melody i” and has
contributed to the spread of perinatal telemedicine. Melody would like to support the improvementof the wellbeing of all mothers and their families during pregnancy, childbirth, and parenthood
through the power of technology. For more information, please visit the Melody International Ltd.
website at https://www.melodyi.net
About ASKA Pharmaceutical Co., Ltd.
Since its foundation in 1920, ASKA has concentrated its management resources in three coreareas: internal medicine, obstetrics and gynecology, and urology, based on its corporate
philosophy “Contribute toward the improvement of people’s health and progress in medicine
through the development of innovative products”. In addition, ASKA has been actively engaged
in the development of new drugs to solve medical needs. For more information, please visit theASKA Pharmaceutical Co., Ltd. website at https://www.aska-pharma.co.jp/english

Inquiries
Melody International Ltd.
Tel: +81-87-813-7362
Email: e-support@melodyi.net
ASKA Pharmaceutical Co., Ltd.
Corporate Planning Department
Tel: +81-3-5484-8366
Email: kouhou@aska-pharma.co.jp